Trial Profile

Physiological Study to Determine the Role of the Melanocortin-4 Receptor in Brain Activity in Women With Hypoactive Sexual Desire Disorder

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 12 Aug 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bremelanotide (Primary)
Indications Female sexual dysfunction
Focus Therapeutic Use

Most Recent Events

09 Aug 2024 Status changed from recruiting to completed.
21 Oct 2022 New trial record
17 Oct 2022 According to Palatin Technologies media release, this was an investigator-sponsored study funded by AMAG Pharmaceuticals Inc. (previous Vyleesi collaboration partner) and the Medical Research Council and National Institute for Health Research of the United Kingdom.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com